Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma

Detalles Bibliográficos
Autores principales: Schneller, Anja, Zojer, Niklas, Bolomsky, Arnold, Ludwig, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409038/
https://www.ncbi.nlm.nih.gov/pubmed/33910332
http://dx.doi.org/10.3324/haematol.2020.277152
_version_ 1783746915589947392
author Schneller, Anja
Zojer, Niklas
Bolomsky, Arnold
Ludwig, Heinz
author_facet Schneller, Anja
Zojer, Niklas
Bolomsky, Arnold
Ludwig, Heinz
author_sort Schneller, Anja
collection PubMed
description
format Online
Article
Text
id pubmed-8409038
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-84090382021-09-08 Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma Schneller, Anja Zojer, Niklas Bolomsky, Arnold Ludwig, Heinz Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-04-29 /pmc/articles/PMC8409038/ /pubmed/33910332 http://dx.doi.org/10.3324/haematol.2020.277152 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letters to the Editor
Schneller, Anja
Zojer, Niklas
Bolomsky, Arnold
Ludwig, Heinz
Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma
title Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma
title_full Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma
title_fullStr Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma
title_full_unstemmed Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma
title_short Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma
title_sort synergistic interaction between hdac and mcl-1 inhibitors through downregulation of bcl-xl in multiple myeloma
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409038/
https://www.ncbi.nlm.nih.gov/pubmed/33910332
http://dx.doi.org/10.3324/haematol.2020.277152
work_keys_str_mv AT schnelleranja synergisticinteractionbetweenhdacandmcl1inhibitorsthroughdownregulationofbclxlinmultiplemyeloma
AT zojerniklas synergisticinteractionbetweenhdacandmcl1inhibitorsthroughdownregulationofbclxlinmultiplemyeloma
AT bolomskyarnold synergisticinteractionbetweenhdacandmcl1inhibitorsthroughdownregulationofbclxlinmultiplemyeloma
AT ludwigheinz synergisticinteractionbetweenhdacandmcl1inhibitorsthroughdownregulationofbclxlinmultiplemyeloma

Ejemplares similares